Expert Analysis

Hepatitis Coinfection and Opportunistic Diseases

Source: CCO Independent Conference Coverage of the 2004 International AIDS Conference*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Hepatitis Coinfection and Opportunistic Diseases


Program Director: John P. Phair, MD

Faculty:

Richard E. Chaisson, MDAndrew T. Pavia, MDBruce Polsky, MD
  • Richard E. Chaisson, MD
  • Andrew T. Pavia, MD
  • Bruce Polsky, MD

CME CREDIT INFORMATION

Release Date: 08/19/04

Expiration Date: 08/18/05


Physicians: maximum of 2.0 AMA PRA Category 1 Credits™

Registered Nurses: 2.6 Nursing CE credits

Pharmacists: 2.25 contact hours (0.23 CEUs)

Status: Please log in to view status

Begin the Expert Analysis

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe new findings on treatment of tuberculosis, immune reconstitution inflammatory syndrome, toxoplasmosis, and other opportunistic infections in HIV-infected patients

  • Discuss the impact of antiretroviral therapy on the liver in HBV- and HCV-coinfected patients

  • Review recent data on the treatment of HIV/HCV-coinfected patients with pegylated interferon + ribavirin regimens


Earn CME credit by reading the expert analysis and commentary on coinfection. Topics covered include:

  • Survival of HCV-Coinfected Patients
  • 12-Week Virologic Response and Outcome in HCV-Coinfected Patients
  • Lopinavir/Ritonavir in Hepatitis B Virus (HBV)- and HCV-Coinfected Patients
  • Adefovir in HBV-Coinfected Patients
  • Isoniazid (INH) for Tuberculosis (TB) Prophylaxis
  • Efavirenz Dosing With Concomitant Rifampin
  • Toxoplasmosis and Other OIs
  • Immune Reconstitution Inflammatory Syndrome (IRIS)
  • Anal Dysplasia
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Pharmacist and nursing credit provided through the cosponsorship of Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.

CCO Resources

CCO Expert Recap of data from the 2004 International AIDS Conference

CCO Expert Recap